IRX3 and Splenomegaly: Three of six IRX3-expressing HSPC recipients developed donor-derived lymphoid leukemia (Figures 7I and 7J); in two cases, the leukemia was T-lineage, and mice exhibited splenomegaly and near total BM involvement (Figures 7K and S7A).